The Group's principal activities are to discover, develop and commercialize drugs for the treatment of human viral and other infectious diseases. Its current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus. .
Alacra Alerts:
Receive alerts on the latest reports on Idenix Pharmaceuticals, Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
